This document discusses the pathophysiology and management of critical hyperglycemia in patients with type 2 diabetes mellitus. It covers the diagnostic criteria and differences between ketoacidosis and hyperosmolar hyperglycemic state. It also provides protocols for managing ketoacidosis and hyperosmolar hyperglycemic state based on guidelines from PERKENI, including continuous insulin therapy. Additionally, it discusses glucose targets for inpatients and prevention strategies, as well as glycemic control for outpatients.

1. Dr. Wahyuddin, M.Kes, SpPD, FINASIM
Critical Hyperglycaemic in patient
with Type 2 Diabetes Melitus

2. Patofisiologi Hiperglikemik pada Pasien Kritis
Langouche, L Van den Bergh G, Gunst J, Critical Care 2021

3. Kriteria Diagnostik KAD dan HHS

4. Perbedaan KAD dan HHS

5. Protokol Manajemen KAD dan HHS
Pedoman Terapi Insulin. PERKENI 2021

6. Protokol Manajemen KAD dan HHS
Pedoman Terapi Insulin. PERKENI 2021

7. Terapi Insulin Kontinu
Pedoman Terapi Insulin. PERKENI 2021

8. Glukosa Target Pasien Rawat Inap

9. Pencegahan
Pedoman Terapi Insulin. PERKENI 2021
Kendali glikemik Pasien Rawat Jalan

10. End Slide
Terimong Genaseh